Detalhe da pesquisa
1.
Next-generation characterization of the Cancer Cell Line Encyclopedia.
Nature
; 569(7757): 503-508, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31068700
2.
The combination of FLT3 and SYK kinase inhibitors is toxic to leukaemia cells with CBL mutations.
J Cell Mol Med
; 24(3): 2145-2156, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31943762
3.
Effects of the multi-kinase inhibitor midostaurin in combination with chemotherapy in models of acute myeloid leukaemia.
J Cell Mol Med
; 24(5): 2968-2980, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31967735
4.
Comparison of effects of midostaurin, crenolanib, quizartinib, gilteritinib, sorafenib and BLU-285 on oncogenic mutants of KIT, CBL and FLT3 in haematological malignancies.
Br J Haematol
; 187(4): 488-501, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31309543
5.
Inhibition of USP10 induces degradation of oncogenic FLT3.
Nat Chem Biol
; 13(12): 1207-1215, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28967922
6.
Anti-leukaemic activity of the TYK2 selective inhibitor NDI-031301 in T-cell acute lymphoblastic leukaemia.
Br J Haematol
; 177(2): 271-282, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28295194
7.
ERK Inhibitor LY3214996-Based Treatment Strategies for RAS-Driven Lung Cancer.
Mol Cancer Ther
; 20(4): 641-654, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33536188
8.
Correction: Evaluation of ERK as a therapeutic target in acute myelogenous leukemia.
Leukemia
; 34(9): 2543, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32144400
9.
A Deregulated HOX Gene Axis Confers an Epigenetic Vulnerability in KRAS-Mutant Lung Cancers.
Cancer Cell
; 37(5): 705-719.e6, 2020 05 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32243838
10.
Rhabdoid Tumors Are Sensitive to the Protein-Translation Inhibitor Homoharringtonine.
Clin Cancer Res
; 26(18): 4995-5006, 2020 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32631955
11.
MDM2 and MDM4 Are Therapeutic Vulnerabilities in Malignant Rhabdoid Tumors.
Cancer Res
; 79(9): 2404-2414, 2019 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30755442
12.
Neuronal differentiation and cell-cycle programs mediate response to BET-bromodomain inhibition in MYC-driven medulloblastoma.
Nat Commun
; 10(1): 2400, 2019 06 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31160565
13.
Evaluation of ERK as a therapeutic target in acute myelogenous leukemia.
Leukemia
; 34(2): 625-629, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31455850